These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 13520053

  • 1. Cytochemical effects of azaserine and DON on ribonucleic acid of Ehrlich ascites tumor cells.
    LINDNER A, LARSEN A.
    AMA Arch Pathol; 1958 Apr; 65(4):415-9. PubMed ID: 13520053
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic heterogeneity of ribonucleic acid in Ehrlich ascites tumor cells.
    YAMANA K.
    Gan; 1959 Sep; 50():201-8. PubMed ID: 13846422
    [No Abstract] [Full Text] [Related]

  • 3. The conservation of ribonucleic acid by Ehrlich ascites tumor cells.
    SCOTT JF, TAFT EB.
    Biochim Biophys Acta; 1958 Apr; 28(1):45-50. PubMed ID: 13535675
    [No Abstract] [Full Text] [Related]

  • 4. [Incorporation of ribonucleic acid labelled with P32 or C-14 into ascites tumor cells].
    HAREL L, HAREL J, LACOUR F.
    C R Hebd Seances Acad Sci; 1961 Oct 30; 253():2000-2. PubMed ID: 13904684
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH, KARNOFSKY DA.
    Am J Physiol; 1958 Oct 30; 195(1):244-50. PubMed ID: 13583156
    [No Abstract] [Full Text] [Related]

  • 6. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM.
    Tex Rep Biol Med; 1957 Oct 30; 15(1):148-53. PubMed ID: 13409287
    [No Abstract] [Full Text] [Related]

  • 7. Paired incorporation of phosphate into ribonucleic acid nucleotides of Ehrlich ascites-tumor cells.
    HADJIOLOV AA, ILKOV AT.
    Biochim Biophys Acta; 1961 Feb 12; 47():217-9. PubMed ID: 13710339
    [No Abstract] [Full Text] [Related]

  • 8. Early cell death due to azaserine treatment of Ehrlich ascites tumor cells: a histochemical comparison of histone with DNA and total protein.
    LINDNER A.
    Acta Unio Int Contra Cancrum; 1960 Feb 12; 16():691-5. PubMed ID: 14417174
    [No Abstract] [Full Text] [Related]

  • 9. The molecular weight of ribonucleic acid prepared from ascites-tumor cells.
    TIMASHEFF SN, BROWN RA, COLTER JS, DAVIES M.
    Biochim Biophys Acta; 1958 Mar 12; 27(3):662-3. PubMed ID: 13535665
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ENHANCEMENT OF THIOINOSINATE SYNTHESIS IN THE EHRLICH ASCITES CARCINOMA BY PRIOR TREATMENT WITH 6-MERCAPTOPURINE OR AZASERINE.
    PATERSON AR.
    Acta Unio Int Contra Cancrum; 1964 Mar 12; 20():1033-6. PubMed ID: 14274687
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Purine synthesis in ascites tumor cells.
    LEPAGE GA, SARTORELLI AC.
    Tex Rep Biol Med; 1957 Mar 12; 15(1):169-80. PubMed ID: 13409290
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the mode of action of azaserine.
    BENNETT LL, SCHABEL FM, SKIPPER HE.
    Arch Biochem Biophys; 1956 Oct 12; 64(2):423-36. PubMed ID: 13363450
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on the pharmacological characterization of a permanent in vitro growing strain of Ehrlich ascites tumor cells].
    Schmid I, Karzel K.
    Arzneimittelforschung; 1968 Dec 12; 18(12):1498-500. PubMed ID: 4976453
    [No Abstract] [Full Text] [Related]

  • 20. [On the modification of glycolysis in Ehrlich ascites tumor cells by phosphorylated fructoses].
    HEISE E, LUEHRS W, GOERLICH M.
    Z Naturforsch B; 1961 Sep 12; 16B():582-5. PubMed ID: 14036143
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.